Paper3754487
Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
Harker WG and 4 others. Cancer Res, 1986. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Papers, record 3754487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3754487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Sarcoma, Experimental | Major topic |
| Verapamil | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Cell Line | |
| Cell Survival | |
| Drug Resistance | |
| Drug Synergism | |
| Female | |
| Humans | |
| Uterine Neoplasms | |
| Vinblastine |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 33303 | NCI NIH HHS | United States | P01CA033303 | PubMed and NIH | NIH RePORTER |
| CA-0777 | NCI NIH HHS | United States | K04CA000777 | PubMed and NIH | NIH RePORTER |
| GM-07065 | NIGMS NIH HHS | United States | PubMed | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39991087 | Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/39991087 | PubMed |
| 30374303 | Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30374303 | PubMed |
| 28276667 | Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion. | J Biomed Res | 2016 | https://conductscience.org/library/papers/28276667 | PubMed |
| 26456750 | Novel delivery approaches for cancer therapeutics. | J Control Release | 2015 | https://conductscience.org/library/papers/26456750 | PubMed |
| 26009590 | Oestrogen enhances cardiotoxicity induced by Sunitinib by regulation of drug transport and metabolism. | Cardiovasc Res | 2015 | https://conductscience.org/library/papers/26009590 | PubMed |
| 8398588 | R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8398588 | PubMed |
| 8004760 | Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8004760 | PubMed |
| 7765325 | Pharmacologic circumvention of multidrug resistance. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765325 | PubMed |
| 7512899 | Anthracycline antibiotics in cancer therapy. Focus on drug resistance. | Drugs | 1994 | https://conductscience.org/library/papers/7512899 | PubMed |
| 3179186 | Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3179186 | PubMed |
| 3165724 | Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3165724 | PubMed |
| 2789934 | Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer--a possible indicator of chemosensitivity. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2789934 | PubMed |
| 2598402 | Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2598402 | PubMed |
| 2569325 | Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2569325 | PubMed |
| 2548560 | A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC). | Br J Cancer | 1989 | https://conductscience.org/library/papers/2548560 | PubMed |
| 2450775 | Enhancement of the cytogenetic efficacy of the antitumor agent bleomycin by the calcium and calmodulin antagonist fendiline. | Experientia | 1988 | https://conductscience.org/library/papers/2450775 | PubMed |
| 2060546 | Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/2060546 | PubMed |
| 1976451 | Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/1976451 | PubMed |
| 1680368 | Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1680368 | PubMed |
| 1671830 | Modulation of mitomycin C-induced multidrug resistance in vitro. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/1671830 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3754487
GET https://conductscience.org/api/papers/v1/3754487/authors